Skip to main content
Clinical Trials/JPRN-jRCTs052220164
JPRN-jRCTs052220164
Recruiting
未知

Effect of a Hypertension-Management App CureApp HT on Urinary Sodium Excretion in CKD Patients: A Randomized Controlled Trial - CureApp HT CKD Trial

Sakaguchi Yusuke0 sites100 target enrollmentFebruary 7, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Chronic Kidney Disease
Sponsor
Sakaguchi Yusuke
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 7, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sakaguchi Yusuke

Eligibility Criteria

Inclusion Criteria

  • 1\) Age 18 years or older
  • 2\) CKD stage1 to 5 patients referred to the outpatient department of nephrology at Osaka University Hospital
  • 3\) History of hypertension (the systolic blood pressure is \>\=140 mmHg and/or the diastolic blood pressure is \>\=90 mmHg) and/or prescription of antihypertensive drugs
  • 4\) Urinary sodium excretion \>\=100 mmol/day
  • 5\) Written informed consent

Exclusion Criteria

  • 1\) Use of other healthcare applications
  • 2\) Inability to use the application (by the patient or family members)

Outcomes

Primary Outcomes

Not specified

Similar Trials